NCT02981303 · Interventional trial
Study of Imprime PGG and Pembrolizumab in Advanced Melanoma and Triple Negative Breast Cancer
Overall registry status Completed
Phase 2
Conditions Advanced Melanoma, Triple-Negative Breast Cancer
Delaware Valley sites
- Thomas Jefferson University Sidney Kimmel Cancer Center · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory